# Hydrofarm Holdings Group, Inc.: overview HYFM · Nasdaq · CIK 1695295 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/hyfm.md) · [Financials](/companies/hyfm/financials.md) · [Filings](/companies/hyfm/filings.md) · [Insiders](/companies/hyfm/insiders.md) Latest reported revenue: [$23.2m](/filings/0001437749-26-028012.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-028012). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [44.0](/filings/0001695295-25-000010.md) | [37.3 d](/filings/0001695295-26-000010.md) | [40.5](/filings/0001628280-25-024915.md) | [39.2](/filings/0001628280-25-039772.md) | [29.4](/filings/0001695295-25-000010.md) | [25.1 d](/filings/0001695295-26-000010.md) | [28.5](/filings/0001437749-26-017373.md) | [23.2](/filings/0001437749-26-028012.md) | | Gross margin | % | [19.4%](/filings/0001695295-25-000010.md) | [4.9% d](/filings/0001695295-26-000010.md) | [17.0%](/filings/0001437749-26-017373.md) | [7.1%](/filings/0001437749-26-028012.md) | [11.6%](/filings/0001695295-25-000010.md) | [8.5% d](/filings/0001695295-26-000010.md) | [6.4%](/filings/0001437749-26-017373.md) | [11.3%](/filings/0001437749-26-028012.md) | | Operating margin | % | [(20.5%)](/filings/0001695295-25-000010.md) | [(40.5%) d](/filings/0001695295-26-000010.md) | [(27.1%)](/filings/0001437749-26-017373.md) | [(34.0%)](/filings/0001437749-26-028012.md) | [(44.1%)](/filings/0001695295-25-000010.md) | [(953.8%) d](/filings/0001695295-26-000010.md) | [(30.6%)](/filings/0001437749-26-017373.md) | [(32.0%)](/filings/0001437749-26-028012.md) | | Net margin | % | [(29.9%)](/filings/0001695295-25-000010.md) | [(46.9%) d](/filings/0001695295-26-000010.md) | [(35.5%)](/filings/0001437749-26-017373.md) | [(43.0%)](/filings/0001437749-26-028012.md) | [(55.8%)](/filings/0001695295-25-000010.md) | [(963.9%) d](/filings/0001695295-26-000010.md) | [(51.2%)](/filings/0001437749-26-017373.md) | [(45.8%)](/filings/0001437749-26-028012.md) | | Diluted EPS | $ per share | [(2.86)](/filings/0001695295-25-000010.md) | not reported | [(3.12)](/filings/0001437749-26-017373.md) | [(3.63)](/filings/0001437749-26-028012.md) | [(3.51)](/filings/0001695295-25-000010.md) | not reported | [(3.07)](/filings/0001437749-26-017373.md) | [(2.23)](/filings/0001437749-26-028012.md) | | Free cash flow | $m | [(5.3) d](/filings/0001695295-25-000010.md) | [2.4 d](/filings/0001695295-26-000010.md) | [(12.0)](/filings/0001437749-26-017373.md) | [1.4 d](/filings/0001437749-26-028012.md) | [(0.2) d](/filings/0001695295-25-000010.md) | [(4.3) d](/filings/0001695295-26-000010.md) | [(0.8)](/filings/0001437749-26-017373.md) | [(0.0) d](/filings/0001437749-26-028012.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [479](/filings/0001628280-23-007313.md) | [345](/filings/0001628280-24-007813.md) | [227](/filings/0001628280-25-010266.md) | [190](/filings/0001695295-26-000010.md) | [134](/filings/0001695295-26-000010.md) | | Gross margin | % | [21.2%](/filings/0001628280-23-007313.md) | [8.5%](/filings/0001628280-24-007813.md) | [16.6%](/filings/0001628280-25-010266.md) | [16.9%](/filings/0001695295-26-000010.md) | [11.3%](/filings/0001695295-26-000010.md) | | Operating margin | % | [(0.6%)](/filings/0001628280-23-007313.md) | [(81.7%)](/filings/0001628280-24-007813.md) | [(21.9%)](/filings/0001628280-25-010266.md) | [(27.4%)](/filings/0001695295-26-000010.md) | [(206.3%)](/filings/0001695295-26-000010.md) | | Net margin | % | [2.8%](/filings/0001628280-23-007313.md) | [(82.8%)](/filings/0001628280-24-007813.md) | [(28.6%)](/filings/0001628280-25-010266.md) | [(35.1%)](/filings/0001695295-26-000010.md) | [(215.9%)](/filings/0001695295-26-000010.md) | | Diluted EPS | $ per share | [0.31](/filings/0001628280-23-007313.md) | [(6.35)](/filings/0001628280-24-007813.md) | [(14.24)](/filings/0001628280-25-010266.md) | [(14.51)](/filings/0001695295-26-000010.md) | [(62.35)](/filings/0001695295-26-000010.md) | | Free cash flow | $m | [(50.5)](/filings/0001628280-23-007313.md) | [13.8](/filings/0001628280-24-007813.md) | [2.8](/filings/0001628280-25-010266.md) | [(3.2)](/filings/0001695295-26-000010.md) | [(15.1)](/filings/0001695295-26-000010.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hyfm/insiders.md) | Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing | | --- | --- | --- | --- | ---: | ---: | ---: | --- | | 2026-10-27 | [Parker Mark S](/insiders/1915363.md) | President, Officer | Purchase (P) | 22,099 | $0.905 | $20.0k | [Form 4](/filings/0001437749-26-034002.md) | ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $59.8k | 70,363 | | Reduced −1,800 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $42.9k | 50,465 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $33.7k | 39,683 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $28.6k | 33,658 | | Reduced −28,928 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $20.4k | 23,985 | | New +23,985 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $15.4k | 18,082 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $13.6k | 16,015 | | Unchanged | | [Compass Ion Advisors, LLC](/funds/1621100.md) | 2026-06-30 | $9.1k | 10,753 | | New +10,753 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $9.0k | 10,613 | | New +10,613 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $4.6k | 5,439 | | Added +2,528 | ## Recent filings [All 445 filings](/companies/hyfm/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 17:24 ET | [8-K](/filings/0001437749-26-033664.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-033664 | | 2026-10-27 | 09:29 ET | [8-K](/filings/0001437749-26-033573.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-033573 | | 2026-10-09 | 16:34 ET | [8-K](/filings/0001437749-26-032448.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-032448 | | 2026-08-14 | 16:12 ET | [10-Q](/filings/0001437749-26-028012.md) | Quarterly report, period 2026-06-30 | 0001437749-26-028012 | | 2026-08-14 | 16:09 ET | [8-K](/filings/0001437749-26-028008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-028008 | | 2026-08-06 | 16:12 ET | [8-K](/filings/0001437749-26-026270.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-026270 | | 2026-07-09 | 16:07 ET | [8-K](/filings/0001437749-26-023198.md) | 3.01 Delisting notice | 0001437749-26-023198 | | 2026-06-26 | 16:32 ET | [8-K](/filings/0001437749-26-021845.md) | 5.07 Shareholder vote results | 0001437749-26-021845 | | 2026-06-22 | 16:02 ET | [8-K](/filings/0001437749-26-021306.md) | 8.01 Other events | 0001437749-26-021306 | | 2026-05-15 | 16:04 ET | [10-Q](/filings/0001437749-26-017373.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017373 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001695295-26-000010.md), filed Mar 27, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bec1bb53-aff0-48cd-a716-3ce3b874bb33) ## About the filer - CIK: 1695295 - Tickers: HYFM - Exchange: Nasdaq - SIC code: 5190 Wholesale-Miscellaneous Nondurable Goods - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.